Daiichi Sankyo (United States)

Daiichi Sankyo (United States)

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 981.8 billion in revenue in 2019. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Daiichi Sankyo (United States), United States, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

50%


Total
Publications

1.1K


Total Open
Publications

569


Total
Citations

35K


Open Access
Percentage

50%


Total
Publications

1.1K


Total Open
Publications

569


Total
Citations

35K

Wikipedia

Website

download

Breakdown

26% 19% 5% 50%

Publisher Open

26%

Both

19%

Other Platform Open

5%

Closed

50%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110120130Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

104

Hybrid 44%

223

No Guarantees 36%

182

Other Platform Open

Domain 85%

237

Institution 26%

74

Public 12%

33

Other Internet 9%

26

Preprint 5%

13

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
236
Europe PMC
Domain
151
Figshare
Public
24
Semantic Scholar
Public
22
DOI
Other Internet
22
Research Square
Preprint
10
University College London - UCL Discovery
Institution
9
KU Leuven - Lirias
Institution
9
Harvard University - Digital Access to Scholarship at Harvard (DASH)
Institution
8
Leiden University - Leiden Repository
Institution
7
1 / 8

Data updated 15 November 2023

Share

Share

Share